A ctDNA result is a number with a unit. Molecules per millilitre, parts per million and allele fraction answer different questions, so a printed number means nothing until its unit and denominator are known.
Circulating tumour DNA (ctDNA) can be reported as a concentration, as a fraction, or as a yes or no call, and the three are not interchangeable. A concentration counts tumour-attributed molecules in a stated volume of plasma. One example is mean tumour molecules per millilitre (MTM/mL), which the I-SPY 2 breast-cancer study of Magbanua and colleagues used for ctDNA across tracked variants. A fraction divides tumour-attributed molecules by a stated total, such as all evaluated alleles at one position (variant allele fraction, VAF) or all evaluated DNA (an estimated tumour fraction). Parts per million (PPM) is a fraction multiplied by one million, so the number is only as meaningful as the fraction it scales: 0.01% is 100 PPM, and 0.00024% is 2.4 PPM, the lowest allele fraction Santonja and colleagues reported for ctDNA detection in breast cancer.
Concentration and fraction can move apart. If two equal one-millilitre aliquots each hold the same number of tumour molecules but one holds more background cell-free DNA, the concentration is unchanged and the fraction falls. A detection call and a reliable amount are also different claims, because the detection limit and the quantitation range are validated separately. Nothing here gives a conversion between assays: MTM/mL cannot be turned into PPM from the printed result, and a VAF of 100 PPM at one variant is not a tumour fraction of 100 PPM.
Showing the technology this term belongs to: Liquid biopsy (ctDNA).
Shares Circulating tumour DNA fraction (and what a negative plasma result means), Cell-free DNA (cfDNA), Minimal / molecular residual disease (MRD), Circulating tumour DNA (ctDNA) and the tags biomarker, measurement.
Shares Minimal / molecular residual disease (MRD), Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA) and the tags biomarker, measurement.
Shares Cell-free DNA (cfDNA), Minimal / molecular residual disease (MRD), Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing.
Shares Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA) and the tag biomarker.
Shares Variant allele frequency (VAF), Minimal / molecular residual disease (MRD), Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing.
Shares Minimal / molecular residual disease (MRD), Circulating tumour DNA (ctDNA), MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
Shares Variant allele frequency (VAF), Cell-free DNA (cfDNA), Minimal / molecular residual disease (MRD), Circulating tumour DNA (ctDNA).
Shares Circulating tumour DNA fraction (and what a negative plasma result means), Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA) and the tag biomarker.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/